Accelerate to discover

Homepage>Discover>Use of the iQue Screener as a versatile tool for in-vitro immunogenicity and immunotoxicity risk assessment

Back to filter

Dec 4, 2019

Micro-CT is a powerful tool for the longitudinal monitoring of bones to acquire bone mass and architectural changes in...

Dec 2, 2019

Catheter blockage by ureolytic biofilm-forming pathogens is a significant problem for health services, with 2,000...

Nov 27, 2019

Learn about new SpectroFlo version 2.2.0. Innovative software tools from Cytek Biosciences and De Novo Software that...

Nov 8, 2019

Hyperpolarized (HP)-13C MR is proven as a viable tool for imaging of neurological disorders often associated with...

Jan 20, 2020

Nov 6, 2019

In this webinar we will describe three recent applications for imaging flow cytometry (IFC), a technology that combines...

Nov 6, 2019

The relatively low T1 contrast, long T1 values at higher fields lead to the necessity to adapt sequences commonly used...

Oct 29, 2019

During this webinar, Dr Pierre Cordelier will discuss the use of IncuCyte Live-Cell Imaging and Analysis, to track gene...

Jan 20, 2020

Oct 8, 2019

We invite you to join us on Friday, October 11 at 8:00 PM CET to hear more about Cytek collaborative...

Use of the iQue Screener as a versatile tool for in-vitro immunogenicity and immunotoxicity risk assessment

Sep 29, 2015

Brecht Hoedemaekers, ImmunXperts

November 12th, 4pm BST

REGISTER NOW

Webinar

Get more info

Head of application support

Riccardo

Pasculli

+420 731 127 717

pasculli@accela.eu

Send Message

Brand profile

IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.